^
CANCER:
Ovarian Serous Adenocarcinoma
Related cancers:
BRAF V600E
Ovarian Serous Adenocarcinoma
binimetinib + encorafenib
Sensitive
:
C1
BRCA2 mutation
Ovarian Serous Adenocarcinoma
olaparib
Sensitive
:
C1
BRCA1 mutation
Ovarian Serous Adenocarcinoma
olaparib
Sensitive
:
C1
KRAS G12D
Ovarian Serous Adenocarcinoma
VS-6766 + VS-6063
Sensitive
:
C3
KRAS G12A
Ovarian Serous Adenocarcinoma
VS-6766 + VS-6063
Sensitive
:
C3
KRAS G12V
Ovarian Serous Adenocarcinoma
VS-6766 + VS-6063
Sensitive
:
C3
Choline elevation
Ovarian Serous Adenocarcinoma
pembrolizumab
Sensitive
:
C3
BRCA1 mutation
Ovarian Serous Adenocarcinoma
AZD1775
Sensitive
:
C4
GOPC-ROS1 fusion
Ovarian Serous Adenocarcinoma
crizotinib
Sensitive
:
C4
ER Y537N
Ovarian Serous Adenocarcinoma
fulvestrant
Sensitive
:
C4
BRCA2 mutation
Ovarian Serous Adenocarcinoma
LY2606368 + LY3023414
Sensitive
:
D
BRAF L485-P490 deletion
Ovarian Serous Adenocarcinoma
LY3009120
Sensitive
:
D
PRMT1 underexpression
Ovarian Serous Adenocarcinoma
carboplatin
Sensitive
:
D
PRMT1 underexpression
Ovarian Serous Adenocarcinoma
cisplatin
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our